益气健脾抗癌法对结肠癌HT-29细胞自噬的作用研究  被引量:3

Effect of Invigorating Qi and Invigorating Spleen Anti-cancer Method on Autophagy of Colon Cancer HT-29 Cells

在线阅读下载全文

作  者:王宁[1] 于婷婷 杨哲 宋文杰 冯晓飞 金迎[1] WAN Ning;YU Tingting;YANG Zhe;SONG Wenjie;FENG Xiaofei;JIN Ying(The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine,Shenyang 110034,Liaoning,China)

机构地区:[1]辽宁中医药大学附属第二医院,辽宁沈阳110034

出  处:《辽宁中医杂志》2022年第2期154-156,225,共4页Liaoning Journal of Traditional Chinese Medicine

基  金:辽宁省自然科学基金指导计划(20180550731)

摘  要:目的探索益气健脾抗癌法对体外培养的结肠癌HT-29细胞自噬作用及相关机制。方法将体外培养的结肠癌HT-29细胞分为高剂量益气健脾抗癌组,中剂量益气健脾抗癌组,低剂量益气健脾抗癌组,及不含药血清对照组。应用Western blot检测各组细胞中Beclin-1、LC3和p62蛋白表达量,吖啶橙染色检测细胞自噬。结果在作用48 h时,与不含药血清对照组相比,益气健脾抗癌法可激活HT-29细胞的自噬(P<0.05)。高剂量组较中、低剂量组对细胞的激活能力差异具有统计学意义,3个剂量组均可降低HT-29细胞的侵袭能力,高剂量组与其他组相比,差异有统计学意义(P<0.05)。结论益气健脾抗癌法可以激活HT-29细胞的自噬,且与剂量呈正相关。Objective To explore the autophagy of colon cancer HT-29 cells cultured in vitro by invigorating Qi and strengthening spleen and anti-cancer method.Methods Colon cancer HT-29 cells cultured in vitro were divided into three groups:high-dose group,medium-dose group,low-dose group,and control group without drug serum.Western blot was used to detect beclin-1,LC3 and P62 protein expressions in each group,and acridine orange staining was used to detect autophagy.Results At 48 h of treatment,compared with the drug-free serum control group,the invigorating Qi and strengthening spleen and anti-cancer method could activate the autophagy of HT-29 cells(P<0.05).The activation ability of hT-29 cells in the high-dose group was statistically different from that in the middle-dose and low-dose groups.The invasion ability of HT-29 cells in the three dose groups was reduced,and the difference between the high-dose group and other groups was significant(P<0.05).Conclusion The invigorating Qi and strengthening spleen and anti-cancer method can activate the autophagy of HT-29 cells,which is positively correlated with the dose.

关 键 词:结肠癌HT-29细胞 益气健脾抗癌 结肠癌 生长抑制 

分 类 号:R285[医药卫生—中药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象